Paternal and maternal use of dupilumab in patients with atopic dermatitis: a case series

Autor: M.A. Middelkamp‐Hup, L.A.A. Gerbens, A.L. Bosma, Ph.I. Spuls

Publikováno v: Clinical and experimental dermatology, 46(6), 1089-1092. Wiley-Blackwell
Clinical and Experimental Dermatology

Dupilumab is a relatively new treatment option for patients with moderate to severe atopic dermatitis. There is a lack of knowledge about the effects of treatment with dupilumab during conception for both men and women, as well as during pregnancy an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::577bf041de9d05cdf95d7543293f4a8c
http://www.scopus.com/inward/record.url?scp=85107200883&partnerID=8YFLogxK

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Classifying atopic dermatitis: a systematic review of phenotypes and associated characteristics

Autor: A.L. Bosma, A. Ascott, R. Iskandar, K. Farquhar, J. Matthewman, M.W. Langendam, A. Mulick, K. Abuabara, H.C. Williams, P.I. Spuls, S.M. Langan, M.A. Middelkamp‐Hup

Publikováno v: Bosma, A L, Ascott, A, Iskandar, R, Farquhar, K, Matthewman, J, Langendam, M W, Mulick, A, Abuabara, K, Williams, H C, Spuls, P I, Langan, S M & Middelkamp-Hup, M A 2022, ' Classifying atopic dermatitis : a systematic review of phenotypes and associated characteristics ', Journal of the European Academy of Dermatology and Venereology, vol. 36, no. 6, pp. 807-819 . https://doi.org/10.1111/jdv.18008

Atopic dermatitis is a heterogeneous disease, accompanied by a wide variation in disease presentation and the potential to identify many phenotypes that may be relevant for prognosis and treatment. We aimed to systematically review previously reporte

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d7089f5b26cd79a6853596ca9fc398a

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Learning from disease registries during a pandemic: Moving toward an international federation of patient registries

Autor: Leslie Castelo-Soccio, Lars E. French, Esther E. Freeman, George J. Hruza, A.L. Bosma, B.W.M. Arents, Henry W. Lim, G. Fletcher, Christian Apfelbacher, Raed Alhusayen, Christopher E.M. Griffiths, Irene Lara-Corrales, Nekma Meah, Satveer K. Mahil, Esther A. Balogh, A.H. Musters, Haley B. Naik, Carsten Flohr, Manja Bloem, Devon E. McMahon, T. Burton, Phyllis I. Spuls, Katherine York, John R. Ingram, Michael D. Kappelman, Catherine H. Smith, Desmond J. Tobin, Steven R. Feldman, Laita Bokhari, Alan D. Irvine, Dmitri Wall, Ian McNicoll, Nicole Fagan, Rodney Sinclair

Publikováno v: Clinics in dermatology, 39(3), 467-478. Elsevier Inc.
Clinics in Dermatology

High-quality dermatology patient registries often require considerable time to develop and produce meaningful data. Development time is influenced by registry complexity and regulatory hurdles that vary significantly nationally and institutionally. T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f61213a54f573c01e0cad41d3335e23f
https://pure.amc.nl/en/publications/learning-from-disease-registries-during-a-pandemic-moving-toward-an-international-federation-of-patient-registries(3d566dfb-5fdb-4b29-9a63-7a6c28b6cfa1).html